{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:55:53Z","timestamp":1787169353288,"version":"build-2736575974"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.addr.2021.113996","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T20:31:08Z","timestamp":1633725068000},"page":"113996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Nanomedicine to fight infectious disease"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-5628","authenticated-orcid":false,"given":"Kathryn M.","family":"Rubey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8437-0161","authenticated-orcid":false,"given":"Jacob S.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2021.113996_b0005","unstructured":"J. Xu, S.L. Murphy, K.D. Kockanek, E. Arias, Mortality in the United States, 2018, NCHS Data Brief., 2020, pp. 1\u20138."},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3810\/pgm.2010.03.2130","article-title":"Burden of community-acquired pneumonia in North American adults","volume":"122","author":"File","year":"2010","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.addr.2021.113996_b0015","unstructured":"Pneumonia, (n.d.). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pneumonia (accessed March 4, 2021)."},{"key":"10.1016\/j.addr.2021.113996_b0020","doi-asserted-by":"crossref","unstructured":"U. Centers for Disease Control, Antibiotic Resistance Threats in the United States, 2019, (n.d.). https:\/\/doi.org\/10.15620\/cdc:82532.","DOI":"10.15620\/cdc:82532"},{"key":"10.1016\/j.addr.2021.113996_b0025","unstructured":"Antimicrobial Resistance Global Report on Surveillance, n.d."},{"key":"10.1016\/j.addr.2021.113996_b0030","doi-asserted-by":"crossref","DOI":"10.1038\/nature.2015.19037","article-title":"Spread of antibiotic-resistance gene does not spell bacterial apocalypse \u2014 yet","author":"Reardon","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.addr.2021.113996_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.addr.2021.113996_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2021.113996_b0045","doi-asserted-by":"crossref","unstructured":"S. Sengupta, M.K. Chattopadhyay, H.-P. Grossart, F. Walsh, J. Lin, E. Cytryn, The multifaceted roles of antibiotics and antibiotic resistance in nature, 1940, https:\/\/doi.org\/10.3389\/fmicb.2013.00047.","DOI":"10.3389\/fmicb.2013.00047"},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ja.2017.62","article-title":"A brief history of antibiotics and select advances in their synthesis","volume":"71","author":"Nicolaou","year":"2018","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08941939.2012.664099","article-title":"History of antibiotics. from salvarsan to cephalosporins","volume":"25","author":"Zaffiri","year":"2012","journal-title":"J. Investig. Surg."},{"issue":"6","key":"10.1016\/j.addr.2021.113996_b0060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/anie.200461471","article-title":"The composition of Ehrlich\u2019s Salvarsan: resolution of a century-old debate","volume":"44","author":"Lloyd","year":"2005","journal-title":"Angew. Chemie Int. Ed."},{"key":"10.1016\/j.addr.2021.113996_b0065","unstructured":"F.R.C.S. Alexander Fleming, On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenz?1E, Br. J. Exp. Pathol. (1929)."},{"key":"10.1016\/j.addr.2021.113996_b0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.phrs.2018.07.005","article-title":"Clinical applications of population pharmacokinetic models of antibiotics: challenges and perspectives","volume":"134","author":"de Velde","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.addr.2021.113996_b0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0924-8579(02)00354-0","article-title":"Antibiotic safety assessment","volume":"21","author":"Rouveix","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2021.113996_b0080","doi-asserted-by":"crossref","unstructured":"J.A. Roberts, C.M.J. Kirkpatrick, J. Lipman, Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients, n.d. https:\/\/doi.org\/10.1093\/jac\/dkq449.","DOI":"10.1093\/jac\/dkq449"},{"key":"10.1016\/j.addr.2021.113996_b0085","doi-asserted-by":"crossref","unstructured":"S. De Biasi, I. Coloretti, A. Cossarizza, Multidrug resistant bacteria in critically ill patients: a step further antibiotic therapy, 2018 https:\/\/doi.org\/10.21037\/jeccm.2018.11.08.","DOI":"10.21037\/jeccm.2018.11.08"},{"key":"10.1016\/j.addr.2021.113996_b0090","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/jac\/dkt129","article-title":"Community-associated Clostridium difficile infection and antibiotics: a meta-analysis","volume":"68","author":"Deshpande","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.addr.2021.113996_b0095","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00431-019-03373-0","article-title":"Are antibiotics a risk factor for the development of necrotizing enterocolitis\u2014case-control retrospective study","volume":"178","author":"Raba","year":"2019","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.addr.2021.113996_b0100","unstructured":"M. Demerec, Origin of bacterial resistance to antibiotics\u2019, n.d. http:\/\/jb.asm.org\/."},{"key":"10.1016\/j.addr.2021.113996_b0105","doi-asserted-by":"crossref","unstructured":"O. Sk\u00f6ld, Sulfonamide resistance Sulfonamide resistance: mechanisms and trends, 2000, https:\/\/doi.org\/10.1054\/drup.2000.0146.","DOI":"10.1054\/drup.2000.0146"},{"key":"10.1016\/j.addr.2021.113996_b0110","unstructured":"L.A. Dever, T.S. Dermody, Mechanisms of Bacterial Resistance to Antibiotics, n.d. https:\/\/jamanetwork.com\/."},{"key":"10.1016\/j.addr.2021.113996_b0115","doi-asserted-by":"crossref","unstructured":"D.B. Clewell, Plasmids, Drug Resistance, and Gene Transfer in the Genus Streptococcus, 1981, http:\/\/mmbr.asm.org\/.","DOI":"10.1128\/mr.45.3.409-436.1981"},{"key":"10.1016\/j.addr.2021.113996_b0120","unstructured":"C. Lee Ventola, The Antibiotic Resistance Crisis Part 1: Causes and Threats, 2015."},{"key":"10.1016\/j.addr.2021.113996_b0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/48.suppl_1.5","article-title":"Determination of minimum inhibitory concentrations","volume":"48","author":"Andrews","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2021.113996_b0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jgar.2018.05.005","article-title":"Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?","volume":"14","author":"Cojutti","year":"2018","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.addr.2021.113996_b0135","first-page":"3","article-title":"Tackling threats and future problems of multidrug-resistant bacteria","volume":"398","author":"Medina","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2021.113996_b0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.addr.2021.113996_b0145","first-page":"310","article-title":"Current concepts in combination antibiotic therapy for critically ill patients, Indian","volume":"18","author":"Ahmed","year":"2014","journal-title":"J Crit. Care Med."},{"key":"10.1016\/j.addr.2021.113996_b0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fpubh.2019.00151","article-title":"The \u201cOld\u201d and the \u201cNew\u201d antibiotics for MDR Gram-negative pathogens: For whom, when, and how","volume":"7","author":"Karaiskos","year":"2019","journal-title":"Front. Public Heal."},{"issue":"8","key":"10.1016\/j.addr.2021.113996_b0155","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41564-020-0723-z","article-title":"A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens","volume":"5","author":"Song","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.addr.2021.113996_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-019-1416-8","article-title":"Cationic antimicrobial peptides: Alternatives and\/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa","volume":"19","author":"Geitani","year":"2019","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.addr.2021.113996_b0165","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41429-019-0221-9","article-title":"Development of a nebramine-cyclam conjugate as an antibacterial adjuvant to potentiate \u03b2-lactam antibiotics against multidrug-resistant P. aeruginosa","volume":"72","author":"Ammeter","year":"2019","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"3","key":"10.1016\/j.addr.2021.113996_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol."},{"issue":"5","key":"10.1016\/j.addr.2021.113996_b0175","first-page":"385","article-title":"Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant\/extensively drug-resistant\/pandrug-resistant bacteria","volume":"24","author":"Bassetti","year":"2018","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.addr.2021.113996_b0180","unstructured":"J.L. Clement, P.S. Jarrett, Antibacterial Silver, n.d."},{"issue":"12","key":"10.1016\/j.addr.2021.113996_b0185","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/jdv.15055","article-title":"Silver absorption and toxicity evaluation of silver wound dressings in 40 patients with chronic wounds","volume":"32","author":"Brouillard","year":"2018","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"issue":"1","key":"10.1016\/j.addr.2021.113996_b0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/15563659609020246","article-title":"Silver products for medical indications: Risk-benefit assessment","volume":"34","author":"Fung","year":"1996","journal-title":"J. Toxicol. - Clin. Toxicol."},{"key":"10.1016\/j.addr.2021.113996_b0195","first-page":"16","article-title":"A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices","volume":"2010","author":"Lansdown","year":"2010","journal-title":"Adv. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.addr.2021.113996_b0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11274-009-0211-3","article-title":"Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria","volume":"26","author":"Lara","year":"2010","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.addr.2021.113996_b0205","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkm496","article-title":"Unexpected antimicrobial effect of statins","volume":"61","author":"Jerwood","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2021.113996_b0210","doi-asserted-by":"crossref","unstructured":"E.P. Figueiredo, J.M. Ribeiro, E.K. Nishio, S. Scandorieiro, A.F. Costa, V.F. Cardozo, A.G. Oliveira, N. Dur\u00e1n, L.A. Panagio, R. Kobayashi, G. Nakazato, New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria, 2019. https:\/\/doi.org\/10.2147\/IJN.S211756.","DOI":"10.2147\/IJN.S211756"},{"key":"10.1016\/j.addr.2021.113996_b0215","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.2147\/IJN.S83953","article-title":"Comparative assessment of the apoptotic potential of silver nanoparticles synthesized by Bacillus tequilensis and Calocybe indica in MDA-MB-231 human breast cancer cells: targeting p53 for anticancer therapy","volume":"10","author":"Gurunathan","year":"2015","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.addr.2021.113996_b0220","doi-asserted-by":"crossref","unstructured":"C. Liao, Y. Li, S.C. Tjong, Bactericidal and Cytotoxic Properties of Silver Nanoparticles, n.d. https:\/\/doi.org\/10.3390\/ijms20020449.","DOI":"10.3390\/ijms20020449"},{"key":"10.1016\/j.addr.2021.113996_b0225","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.12563","article-title":"The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens","volume":"279","author":"Kim","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2021.113996_b0230","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2147\/IDR.S156995","article-title":"Understanding antibiotic resistance via outer membrane permeability","volume":"11","author":"Ghai","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.addr.2021.113996_b0235","doi-asserted-by":"crossref","unstructured":"M. Ghosh, P.A. Miller, U. M\u00f6, W.D. Claypool, V.A. Schroeder, W.R. Wolter, M. Suckow, H. Yu, S. Li, W. Huang, J. Zajicek, M.J. Miller, Targeted Antibiotic Delivery: Selective Siderophore Conjugation with Daptomycin Confers Potent Activity against Multidrug Resistant Acinetobacter baumannii Both in Vitro and in Vivo, 2017. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00102.","DOI":"10.1021\/acs.jmedchem.7b00102"},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/vim.2006.19.147","article-title":"Cellular immunity and lung injury in respiratory virus infection","volume":"19","author":"Bruder","year":"2006","journal-title":"Viral Immunol."},{"key":"10.1016\/j.addr.2021.113996_b0245","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0033-1351122","article-title":"Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic","volume":"34","author":"Hendrickson","year":"2013","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2021.113996_b0250","unstructured":"Z. Wang, H. Liu, S.H. Yang, T. Wang, C. Liu, Y. Charles Cao, Nanoparticle-based artificial RNA silencing machinery for antiviral therapy, n.d. https:\/\/doi.org\/10.1073\/pnas.1207766109\/-\/DCSupplemental."},{"key":"10.1016\/j.addr.2021.113996_b0255","doi-asserted-by":"crossref","unstructured":"C.B. Landersdorfer, J.B. Bulitta, F. S\u00f6rgel, Pharmacokinetics and Pharmacodynamics of Antibiotics in Bone, 2015. https:\/\/doi.org\/10.1002\/9781118581742.ch3.","DOI":"10.1002\/9781118581742.ch3"},{"key":"10.1016\/j.addr.2021.113996_b0260","doi-asserted-by":"crossref","unstructured":"D.E. Griffith, T. Aksamit, B.A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S.M. Holland, R. Horsburgh, G. Huitt, M.F. Iademarco, M. Iseman, K. Olivier, S. Ruoss, C.F. von Reyn, J. Richard, J. Wallace, K. Winthrop, An Official ATS\/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases 175 (2012) 367\u2013416. https:\/\/doi.org\/10.1164\/RCCM.200604-571ST.","DOI":"10.1164\/rccm.200604-571ST"},{"issue":"1","key":"10.1016\/j.addr.2021.113996_b0265","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4049\/jimmunol.0900274","article-title":"Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of NeuroAIDS","volume":"183","author":"Dou","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2021.113996_b0270","article-title":"Staphylococcus saccharolyticus infection: case series with a PRISMA-compliant systemic review","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.addr.2021.113996_b0275","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1021\/pr0504079","volume":"5","author":"Lok","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.addr.2021.113996_b0280","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/femsre\/fux010","article-title":"Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria","volume":"010","author":"Hall","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1574-695X.2012.00960.x","article-title":"The interconnection between biofilm formation and horizontal gene transfer","volume":"65","author":"Madsen","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.addr.2021.113996_b0290","doi-asserted-by":"crossref","unstructured":"Y. Qiu, Y. Wu, B. Lu, G. Zhu, T. Gong, R. Wang, Q. Peng, Y. Li, Inhibition of methicillin-resistant Staphylococcus aureus (MRSA) biofilm by cationic poly (D, L-lactide-co-glycolide) nanoparticles, 36 (2020) 159\u2013168. https:\/\/doi.org\/10.1080\/08927014.2020.1740687.","DOI":"10.1080\/08927014.2020.1740687"},{"key":"10.1016\/j.addr.2021.113996_b0295","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41385-019-0158-0","article-title":"Regulatory cytokine function in the respiratory tract","volume":"12","author":"Branchett","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2021.113996_b0300","doi-asserted-by":"crossref","unstructured":"Y. Yang, Y. Ding, B. Fan, Y. Wang, Z. Mao, W. Wang, J. Wu, Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis (2020). https:\/\/doi.org\/10.1016\/j.jconrel.2020.02.030.","DOI":"10.1016\/j.jconrel.2020.02.030"},{"key":"10.1016\/j.addr.2021.113996_b0305","unstructured":"Mechanism of action of AmBisome\u00ae (amphotericin B) liposome for injection, n.d."},{"issue":"6","key":"10.1016\/j.addr.2021.113996_b0310","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1128\/AAC.41.6.1275","article-title":"Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients","volume":"41","author":"Heinemann","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2021.113996_b0315","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jac\/35.4.509","article-title":"Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans","volume":"35","author":"Van Etten","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2021.113996_b0320","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.46.3.828-833.2002","article-title":"Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans","volume":"46","author":"Bekersky","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2021.113996_b0325","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02383-17","article-title":"The viscoelastic properties of the fungal cell wall allow traffic of ambisome as intact liposome vesicles","volume":"9","author":"Walker","year":"2018","journal-title":"MBio"},{"issue":"3","key":"10.1016\/j.addr.2021.113996_b0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/1120009X.2017.1306183","article-title":"Liposomal amphotericin B (AmBisome\u00ae) at beginning of its third decade of clinical use","volume":"29","author":"Aversa","year":"2017","journal-title":"J. Chemother."},{"key":"10.1016\/j.addr.2021.113996_b0335","unstructured":"FDA, ARIKAYCE [package insert], n.d. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/207356s000lbl.pdf (accessed September 3, 2021)."},{"key":"10.1016\/j.addr.2021.113996_b0340","article-title":"Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2021.113996_b0345","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2147\/DDDT.S146111","article-title":"The use of amikacin liposome inhalation suspension (Arikayce) in the treatment of refractory nontuberculous mycobacterial lung disease in adults","volume":"14","author":"Khan","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2021.113996_b0350","unstructured":"Drug Approval Package: Ambisome (Amphotericin B) NDA# 050740, (n.d.). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/97\/050740_ambisome_toc.cfm (accessed September 3, 2021)."},{"key":"10.1016\/j.addr.2021.113996_b0355","doi-asserted-by":"crossref","unstructured":"D.E. Griffith, G. Eagle, R. Thomson, T.R. Aksamit, N. Hasegawa, K. Morimoto, D.J. Addrizzo-Harris, A.E. O\u2019Donnell, T.K. Marras, P.A. Flume, M.R. Loebinger, L. Morgan, L.R. Codecasa, A.T. Hill, S.J. Ruoss, J.-J. Yim, F.C. Ringshausen, S.K. Field, J. V. Philley, J. Richard J. Wallace, J. van Ingen, C. Coulter, J. Nezamis, K.L. Winthrop, Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study, 198 (2018) 1559\u20131569. https:\/\/doi.org\/10.1164\/RCCM.201807-1318OC.","DOI":"10.1164\/rccm.201807-1318OC"},{"key":"10.1016\/j.addr.2021.113996_b0360","doi-asserted-by":"crossref","unstructured":"M.R. Holt, E.D. Chan, Chronic Cavitary Infections Other than Tuberculosis, in: J. Thorac. Imaging, Lippincott Williams and Wilkins, 2018, pp. 322\u2013333. https:\/\/doi.org\/10.1097\/RTI.0000000000000345.","DOI":"10.1097\/RTI.0000000000000345"},{"key":"10.1016\/j.addr.2021.113996_b0365","first-page":"1","article-title":"Cavitary pneumonia: a complication of antibiotic noncompliance","volume":"2020","author":"Cotton","year":"2020","journal-title":"Case Rep. Pulmonol."},{"key":"10.1016\/j.addr.2021.113996_b0370","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MCP.0000000000000571","article-title":"Necrotizing pneumonia (aetiology, clinical features and management)","volume":"25","author":"Krutikov","year":"2019","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.addr.2021.113996_b0375","article-title":"Management of necrotizing pneumonia and pulmonary gangrene: a case series and review of the literature","author":"Chatha","year":"2014","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.addr.2021.113996_b0380","first-page":"94","article-title":"Antibiotic therapy of pleural empyema","volume":"6","author":"Hughes","year":"1991","journal-title":"Semin. Respir. Infect."},{"issue":"1","key":"10.1016\/j.addr.2021.113996_b0385","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00423-016-1498-9","article-title":"Stage-directed therapy of pleural empyema, Langenbeck\u2019s","volume":"402","author":"Reichert","year":"2017","journal-title":"Arch. Surg."},{"key":"10.1016\/j.addr.2021.113996_b0390","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0395","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.gastro.2018.10.024","article-title":"Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges","volume":"156","author":"Baumert","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2021.113996_b0400","doi-asserted-by":"crossref","unstructured":"D.K. Li, R.T. Chung, Overview of direct-acting antiviral drugs and drug resistance of hepatitis C virus, in: Methods Mol. Biol., Humana Press Inc., 2019, pp. 3\u201332. https:\/\/doi.org\/10.1007\/978-1-4939-8976-8_1.","DOI":"10.1007\/978-1-4939-8976-8_1"},{"key":"10.1016\/j.addr.2021.113996_b0405","first-page":"Doc04","article-title":"Influenza viruses - antiviral therapy and resistance","volume":"5","author":"Duwe","year":"2017","journal-title":"GMS Infect. Dis."},{"issue":"3","key":"10.1016\/j.addr.2021.113996_b0410","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cld.2010.05.004","article-title":"Drug resistance in antiviral therapy","volume":"14","author":"Locarnini","year":"2010","journal-title":"Clin. Liver Dis."},{"issue":"7159","key":"10.1016\/j.addr.2021.113996_b0415","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/bmj.317.7159.660","article-title":"Antiviral drug resistance","volume":"317","author":"Pillay","year":"1998","journal-title":"Br. Med. J."},{"key":"10.1016\/j.addr.2021.113996_b0420","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jac\/2.3.223","article-title":"Drug resistance and antiviral agents","volume":"2","author":"Oxford","year":"1976","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2021.113996_b0425","doi-asserted-by":"crossref","unstructured":"A.L. Rasmussen, Host factors involved in ebola virus replication, in: Curr. Top. Microbiol. Immunol., Springer Verlag, 2018, pp. 113\u2013150. https:\/\/doi.org\/10.1007\/82_2017_27.","DOI":"10.1007\/82_2017_27"},{"issue":"6","key":"10.1016\/j.addr.2021.113996_b0430","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.coviro.2012.10.008","article-title":"Host factors and measles virus replication","volume":"2","author":"Delpeut","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.addr.2021.113996_b0435","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/v2020566","article-title":"A host of factors regulating influenza virus replication","volume":"2","author":"Mehle","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.addr.2021.113996_b0440","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1183\/09031936.00186214","article-title":"Influenza virus-induced lung injury: pathogenesis and implications for treatment","volume":"45","author":"Herold","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2021.113996_b0445","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00168-19","article-title":"Host-directed antiviral therapy","volume":"33","author":"Kumar","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.addr.2021.113996_b0450","doi-asserted-by":"crossref","unstructured":"R.M. Donlan, Biofilms: Microbial Life on Surfaces, 2002. http:\/\/www.microbelibrary.org\/.","DOI":"10.3201\/eid0809.020063"},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0455","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2021.113996_b0460","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","article-title":"Implant infections: adhesion, biofilm formation and immune evasion","volume":"16","author":"Arciola","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.addr.2021.113996_b0465","doi-asserted-by":"crossref","unstructured":"S.L. Percival, P. Kite, Intravascular catheters and biofilm control, J. Vasc. Access. 8 (n.d.) 69\u201380. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17534791.","DOI":"10.1177\/112972980700800202"},{"key":"10.1016\/j.addr.2021.113996_b0470","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12866-019-1596-2","article-title":"Microbial biofilm correlates with an increased antibiotic tolerance and poor therapeutic outcome in infective endocarditis","volume":"19","author":"Di Domenico","year":"2019","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.addr.2021.113996_b0475","doi-asserted-by":"crossref","unstructured":"B. Yaban, J. Kikhneyid, M. Musci, A.P. 1\u00a4, J. Schmidt, M. Hajduczenia, F. Schoenrath, V. Falkid, A. Moter, Aerococcus urinae \u2013 A potent biofilm builder in endocarditis (2020) https:\/\/doi.org\/10.1371\/journal.pone.0231827.","DOI":"10.1371\/journal.pone.0231827"},{"key":"10.1016\/j.addr.2021.113996_b0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcma.2017.07.012","article-title":"Bacterial biofilm and associated infections","volume":"81","author":"Jamal","year":"2018","journal-title":"J. Chinese Med. Assoc."},{"key":"10.1016\/j.addr.2021.113996_b0485","doi-asserted-by":"crossref","unstructured":"F.S. Haddad, A. Ngu, J.J. Negus, Prosthetic joint infections and cost analysis?, in: Adv. Exp. Med. Biol., Springer New York LLC, 2017, pp. 93\u2013100, https:\/\/doi.org\/10.1007\/5584_2016_155.","DOI":"10.1007\/5584_2016_155"},{"issue":"8","key":"10.1016\/j.addr.2021.113996_b0490","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arth.2012.02.022","article-title":"Economic burden of periprosthetic joint infection in the united states","volume":"27","author":"Kurtz","year":"2012","journal-title":"J. Arthroplasty."},{"issue":"8","key":"10.1016\/j.addr.2021.113996_b0495","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1021\/es103450g","article-title":"Diffusion of nanoparticles in a biofilm","volume":"45","author":"Peulen","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.addr.2021.113996_b0500","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jbm.b.31615","article-title":"ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli","volume":"93B","author":"Banoee","year":"2010","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"issue":"5","key":"10.1016\/j.addr.2021.113996_b0505","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00253-010-2687-z","article-title":"Structural determinants of antimicrobial activity in polymers which mimic host defense peptides","volume":"87","author":"Palermo","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0510","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3201\/eid0502.990206","article-title":"Bacterial toxins: friends or foes?","volume":"5","author":"Schmitt","year":"1999","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.addr.2021.113996_b0515","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.addr.2015.04.001","article-title":"Engineered nanoparticles mimicking cell membranes for toxin neutralization","volume":"90","author":"Fang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.113996_b0520","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nbt.3037","article-title":"Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice","volume":"33","author":"Henry","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"43","key":"10.1016\/j.addr.2021.113996_b0525","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1073\/pnas.1714267114","article-title":"Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management","volume":"114","author":"Thamphiwatana","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.addr.2021.113996_b0530","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.matt.2020.05.017","article-title":"Calming Cytokine Storm in Pneumonia by Targeted Delivery of TPCA-1 Using Platelet-Derived Extracellular Vesicles","volume":"3","author":"Ma","year":"2020","journal-title":"Matter"},{"key":"10.1016\/j.addr.2021.113996_b0535","doi-asserted-by":"crossref","first-page":"eaax7964","DOI":"10.1126\/sciadv.aax7964","article-title":"Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke","volume":"5","author":"Zhang","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2021.113996_b0540","unstructured":"S. Spence, M.K. Greene, F. Fay, E. Hams, S.P. Saunders, U. Hamid, M. Fitzgerald, J. Beck, B.K. Bains, P. Smyth, E. Themistou, D.M. Small, D. Schmid, C.M. O\u2019kane, D.C. Fitzgerald, S.M. Abdelghany, J.A. Johnston, P.G. Fallon, J.F. Burrows, D.F. Mcauley, A. Kissenpfennig, C.J. Scott, Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation, n.d. www.ScienceTranslationalMedicine.org (accessed March 12, 2021)."},{"issue":"11","key":"10.1016\/j.addr.2021.113996_b0545","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s00449-020-02395-5","article-title":"Precise engineering of neutrophil membrane coated with polymeric nanoparticles concurrently absorbing of proinflammatory cytokines and endotoxins for management of sepsis","volume":"43","author":"Wu","year":"2020","journal-title":"Bioprocess Biosyst. Eng."},{"key":"10.1016\/j.addr.2021.113996_b0550","unstructured":"V. Kumar, A. Abbas, N. Fausto, J. Aster, Robbins and Coutran\u2019s Pathologic Basis of Disease, 2009."},{"key":"10.1016\/j.addr.2021.113996_b0555","doi-asserted-by":"crossref","unstructured":"M.R. Distasi, K. Ley, Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability, n.d. https:\/\/doi.org\/10.1016\/j.it.2009.07.012.","DOI":"10.1016\/j.it.2009.07.012"},{"key":"10.1016\/j.addr.2021.113996_b0560","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jac\/dks379","article-title":"The enhanced permeability retention effect: a new paradigm for drug targeting in infection","volume":"68","author":"Azzopardi","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.addr.2021.113996_b0565","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0168-3659(01)00402-3","article-title":"Microscopic localization of PEG-liposomes in a rat model of focal infection","volume":"75","author":"Laverman","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.113996_b0570","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12951-019-0537-4","article-title":"Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles","volume":"17","author":"Wang","year":"2019","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0575","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0928-0987(01)00218-4","article-title":"In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres","volume":"15","author":"Prior","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7578","key":"10.1016\/j.addr.2021.113996_b0580","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody-antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.addr.2021.113996_b0585","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1016\/j.biomaterials.2014.04.092","article-title":"X-ray CT and pneumonia inhibition properties of gold-silver nanoparticles for targeting MRSA induced pneumonia","volume":"35","author":"Huo","year":"2014","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.addr.2021.113996_b0590","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1021\/acs.nanolett.8b02229","article-title":"Nanoparticles targeted against cryptococcal pneumonia by interactions between chitosan and its peptide ligand","volume":"18","author":"Tang","year":"2018","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.addr.2021.113996_b0595","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ja.2015.98","article-title":"A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics","volume":"69","author":"Renwick","year":"2016","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.addr.2021.113996_b0600","doi-asserted-by":"crossref","unstructured":"B. Spellberg, The future of antibiotics, n.d. http:\/\/ccforum.com\/content\/18\/3\/228.","DOI":"10.1186\/cc13948"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21003896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21003896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:04:13Z","timestamp":1759208653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21003896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":120,"alternative-id":["S0169409X21003896"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.113996","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine to fight infectious disease","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.113996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113996"}}